MUCH - Montreal Neurological Institute & Hospital

3801 Rue Université
Montreal, Quebec H3A 2B4

We've found

1 trials

at this facility

A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Montreal,

Use our guide to learn which trials are right for you!